X0206 3 2015-08-26 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001651755 Curtis Eric C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 President, U.S. Commercial Stock Option (right to buy) 19.52 2025-08-04 Common Stock 40000 D Stock Option (right to buy) 20.93 2024-11-03 Common Stock 65000 D 25% of the shares of common stock underlying this stock option award will vest on August 4, 2016, with the remaining 75% of the shares of common stock underlying this stock option award vesting thereafter in equal monthly installments through August 4, 2019, subject to the Reporting Person's continued employment with the Issuer. The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the NASDAQ Global Select Market on the date of grant. 25% of the shares of common stock underlying this stock option award will vest on November 3, 2015, with the remaining 75% of the shares of common stock underlying this stock option award vesting thereafter in equal monthly installments through November 3, 2018, subject to the Reporting Person's continued employment with the Issuer. /s/ Jennifer Fitzpatrick, attorney-in-fact 2015-09-04